Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical
Alkem Laboratories Ltd Q4FY25; 6% rise in Profits
Categories
Pharmaceutical
Ajanta Pharma Ltd Q4FY25; 11% rise in Profits
Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).
Jubilant Ingrevia Ltd Q4FY25; 155% rise in Profits
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our
Abbott India Ltd Q4FY25; 87% rise in Profits
Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within
Torrent Pharmaceuticals Ltd Q4FY25; 11% rise in Profits
Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
Alembic Pharmaceuticals Ltd Q4FY25; 12% fall in Profits
Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company
Dr. Reddy’s Laboratories Ltd Q4FY25; 22% rise in Profits
Company Overview: Dr. Reddy's Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active
Glaxosmithkline Pharmaceuticals Ltd Q3FY25; 400% rise in Profits
GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site) Financial Results:
ERIS Lifesciences Ltd Q3FY25; 14% fall in Profits
ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd reported Revenues
Dr Lal Pathlabs Ltd Q3FY25; 20% rise in Profits
Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where
Sanofi India Ltd Q3FY25; 34% fall in Profits
Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for
Cipla Ltd Q3FY25; 47% rise in Profits
Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157) Financial Results: Cipla Ltd reported Revenues for Q3FY25
Pfizer Ltd Q3FY25; 2% fall in Profits
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also
Aurobindo Pharma Ltd Q3FY25; 10% fall in Profits
Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report
Astrazeneca Pharma India Ltd Q3FY25; 69% fall in Profits
AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products. Financial Results: Astrazeneca Pharma India
Ipca Laboratories Ltd Q3FY25; 25% rise in Profits
Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals. Financial Results: Ipca Laboratories Ltd reported Revenues for Q3FY25 of ₹2,245.00
Alkem Laboratories Ltd Q3FY25; 6% rise in Profits
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical
Alembic Pharmaceuticals Ltd Q3FY25; 23% fall in Profits
Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company
Ajanta Pharma Ltd Q3FY25; 11% rise in Profits
Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).
Abbott India Ltd Q3FY25; 88% fall in Profits
Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within
ZYDUSLIFE Q3 2024-2025 Call Highlights: Profit Jump, Robust Margins & Expansion Plans!
Zydus Lifesciences Ltd., a leading Indian Pharmaceutical company, in its Q3 earnings call discussed strong performance across multiple segments, with US business